1
TITLE: Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma  Full Text
AUTHORS: Luca Arcaini; Thierry Lamy; Jan Walewski; David Belada; Jiri Mayer; John Radford; Wojciech Jurczak; Franck Morschhauser; Julia Alexeeva; Simon Rule; Jose Cabecadas; Elias Campo; Stefano A Pileri; Tsvetan Biyukov; Meera Patturajan; Marie Laure Casadebaig Bravo; Marek Trneny;
PUBLISHED: 2018, SOURCE: BRITISH JOURNAL OF HAEMATOLOGY, VOLUME: 180, ISSUE: 2
INDEXED IN: WOS
2
TITLE: Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
AUTHORS: Herve Tilly; Franck Morschhauser; Olivier Casasnovas; Thierry Jo Molina; Pierre Feugier; Steven Le Gouill; Corinne Haioun; Olivier Tournilhac; Reda Bouabdallah; Jean Gabarre; Thierry Lamy; Jose Cabecadas; Stephanie Becker; Fabrice Jardin; Nicolas Mounier; Gilles Salles;
PUBLISHED: 2018, SOURCE: LANCET HAEMATOLOGY, VOLUME: 5, ISSUE: 9
INDEXED IN: Scopus WOS
3
TITLE: Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study. Statin use in follicular lymphoma  Full Text
AUTHORS: Emmanuel Bachy; Jane A Estell; Eric Van de Neste; Reda Bouabdallah; Joan Bargay; Alain Delmer; Benedicte Gelas Dore; Maria Gomes da Silva; Olivier Fitoussi; David Belada; Herve Maisonneuve; Tanin Intragumtornchai; Thierry Lamy; Peggy Dartigues; John Francis Seymour; Gilles Salles;
PUBLISHED: 2016, SOURCE: AMERICAN JOURNAL OF HEMATOLOGY, VOLUME: 91, ISSUE: 4
INDEXED IN: Scopus WOS CrossRef